Trexquant Investment »

Trevi Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.5M 243k 18.65
2025-06-30 $186k 34k 5.47

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Put Option (MU)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Intuit Call Option (INTU)
Costco Wholesale Corporation Put Option (COST)
Palantir Technologies Cl A Put Option (PLTR)
Broadcom Call Option (AVGO)
Eli Lilly & Co. Call Option (LLY)

View all positions for Trexquant Investment

Top funds holding Trevi Therapeutics

NEA Management Company
FMR
BlackRock
Frazier Life Sciences Management
Wellington Management Company
Vanguard Capital Management
Vivo Capital
Woodline Partners
Vestal Point Capital
MPM Oncology Impact Management
Frontier Capital Management
Geode Capital Management
Marshall Wace
State Street Corporation
Eventide Asset Management

View all funds holding Trevi Therapeutics